UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Montauk Renewables
MNTK
$255M
| $349K | ﹤0.01% |
+34,752
| New | +$414K |
|
2427
Smith & Wesson
SWBI
$637M
| $348K | ﹤0.01% |
26,477
| – | – |
|
2428
Liquidity Services
LQDT
$1.32B
| $348K | ﹤0.01% |
25,858
+12,458
| +93% | +$183K |
|
|
LUCK
2429
Lucky Strike Entertainment
LUCK
$911M
| $347K | ﹤0.01% |
+32,789
| New | +$349K |
|
|
RNAM
2430
DELISTED
Avidity Biosciences
RNAM
| $345K | ﹤0.01% |
23,722
| – | – |
|
2431
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $344K | ﹤0.01% |
35,490
| – | – |
|
2432
Seres Therapeutics
MCRB
$48.4M
| $343K | ﹤0.01% |
5,004
+971
| +24% | +$83.7K |
|
2433
UWM Holdings
UWMC
$434M
| $343K | ﹤0.01% |
96,942
| – | – |
|
2434
AbCellera Biologics
ABCL
$2.12B
| $341K | ﹤0.01% |
+31,998
| New | +$271K |
|
2435
Butterfly Network
BFLY
$2.35B
| $340K | ﹤0.01% |
110,737
-71,266
| -39% | -$246K |
|
2436
Rush Street Interactive
RSI
$2.88B
| $338K | ﹤0.01% |
72,457
-1,517,825
| -95% | -$9.04M |
|
|
LL
2437
DELISTED
LL Flooring Holdings, Inc.
LL
| $337K | ﹤0.01% |
35,954
-1,915
| -5% | -$23.4K |
|
2438
Caribou Biosciences
CRBU
$164M
| $337K | ﹤0.01% |
62,018
+31,718
| +105% | +$242K |
|
2439
Movado Group
MOV
$841M
| $336K | ﹤0.01% |
10,867
+1,589
| +17% | +$55.7K |
|
|
REVG
2440
DELISTED
REV Group
REVG
| $336K | ﹤0.01% |
30,882
-2,248
| -7% | -$26.6K |
|
|
DX
2441
Dynex Capital
DX
$3.21B
| $334K | ﹤0.01% |
20,989
-33,280
| -61% | -$529K |
|
|
SP
2442
DELISTED
SP Plus Corporation
SP
| $334K | ﹤0.01% |
10,857
| – | – |
|
|
IDEX
2443
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $333K | ﹤0.01% |
4,025
+867
| +27% | +$78.1K |
|
2444
Duolingo
DUOL
$6.12B
| $333K | ﹤0.01% |
3,800
+1,200
| +46% | +$106K |
|
|
SOVO
2445
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $329K | ﹤0.01% |
+20,700
| New | +$301K |
|
2446
Bar Harbor Bankshares
BHB
$666M
| $328K | ﹤0.01% |
12,682
| – | – |
|
2447
GDS Holdings
GDS
$6.41B
| $328K | ﹤0.01% |
9,817
-331,912
| -97% | -$10.3M |
|
2448
Lexicon Pharmaceuticals
LXRX
$1.1B
| $327K | ﹤0.01% |
175,950
+92,076
| +110% | +$176K |
|
2449
EVgo
EVGO
$229M
| $326K | ﹤0.01% |
+54,221
| New | +$516K |
|
2450
Arrow Financial
AROW
$652M
| $325K | ﹤0.01% |
10,851
-5,262
| -33% | -$158K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.